Medical Marijuana legalization is spreading throughout the country. As additional medical research is completed and data on usage is collected, additional conditions are being added to the list of qualifying conditions.
“A bill introduced Thursday in the New Hampshire state assembly seeks to add post-traumatic stress disorder to the list of ailments eligible for medical marijuana treatment, which was legalized in 2013 but remains hard to obtain in the Granite state.
The proposed legislation comes as New Hampshire grapples with an opioid and heroin addiction and overdose crisis.
Medical marijuana advocates argue that better access to cannabis would offer an alternative means of pain relief to people now using painkillers or heroin. In 2015 the state’s medical examiner attributed 385 deaths to opiates, almost double the 192 fatalities in 2013, according to New Hampshire Public Radio.
Also, adding PTSD to the list of illnesses approved for cannabis treatment could provide another option to people who’ve found no relief with standard anti-anxiety or antidepressant medication, advocates say.
A University of New Hampshire poll last year found strong backing for the legalization of both medical and recreational marijuana, with support levels growing each year.”
Read more from this Source: PTSD Latest Battleground for Medical Pot | Al Jazeera America
Just as it is important for us o continue medical research, it is important for marijuana businesses to be collecting information, not just from seed to sale, but from seed to use.
To discuss strategies for collecting additional data on patients, contact us.
